logo
Plus   Neg
Share
Email

Gas Natural FY12 Profit Declines

Gas Natural Inc. (EGAS) Tuesday reported a drop in profit for the fiscal year 2012, due mainly to higher operating expenses.

Net income for the period declined to $5.4 million or $0.66 per share from $5.8 million or $0.92 per share last year.

Net income from the natural gas operations segment increased by $140 thousand, driven primarily by customer growth and colder weather in most of its service territories. This was, however, offset by net losses within the company's marketing and production operations segment due to an impairment charge of $790 thousand.

Fiscal-year 2012 net revenues grew to $99.2 million from $91.5 million last year.

Operating expenses increased to $28.8 million from $25.71 million last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT